Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Jinghui Pharmaceutical is a pharmaceutical enterprise located in Meihekou City, Jilin Province, China, focused on the production and distribution of Traditional Chinese Medicines (TCM) and chemical drugs. The company maintains a diverse portfolio that includes treatments for respiratory conditions, cardiovascular diseases, and general pain management. Operating under strict Good Manufacturing Practice (GMP) standards, Jilin Jinghui produces various dosage forms such as capsules, tablets, and granules. The firm plays a significant role in the regional healthcare supply chain, emphasizing the modernization of traditional herbal remedies alongside conventional pharmacotherapy. Their business model integrates research, development, and large-scale manufacturing to serve the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Jinghui Pharmaceutical.